Institution
Innlandet Hospital Trust
Healthcare•Brumunddal, Norway•
About: Innlandet Hospital Trust is a healthcare organization based out in Brumunddal, Norway. It is known for research contribution in the topics: Population & Dementia. The organization has 387 authors who have published 1302 publications receiving 37753 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Based on toxicological, clinical, and epidemiological knowledge, the status regarding possible deleterious health effects from occupational exposure to metallic mercury (Hg) in dental practice is reviewed.
44 citations
••
TL;DR: The results indicate that improvement in the medical state, functional status and/or emotional condition of elderly medically hospitalised patients may improve their QOL.
Abstract: Aim: The present study describes the quality of life (QOL) and explores health-related factors associated with domains of the QOL in the acutely ill and hospitalised elderly Method: In all, 484 elderly (65–101 years, 241 men) patients hospitalised in an acute medical unit participated Their QOL (in its overall and physical, psychological, social and environmental domains) was assessed with the World Health Organisation's WHOQOL-BREF The QOL was explored with multiple linear regression analysis Health-related variables controlled for socio-demographic background were the independent variables Results: The overall QOL was good in two-thirds of the elderly patients In multiple linear regression models, lower physical QOL was significantly associated with a number of medications, impaired personal activities of daily living (PADL), impaired cognition, depression and anxiety Lower psychological QOL was significantly associated with impaired PADL, impaired cognition, depression and anxiety Lower social
44 citations
••
TL;DR: Survivors of childhood acute lymphoblastic leukemia (ALL) are at risk for late cardiotoxic effects of cancer treatment, but conflicting evidence exists on the effects of anthracyclines on left ventricular (LV) diastolic function and exercise capacity.
Abstract: Background
Survivors of childhood acute lymphoblastic leukemia (ALL) are at risk for late cardiotoxic effects of cancer treatment, but conflicting evidence exists on the effects of anthracyclines on left ventricular (LV) diastolic function and exercise capacity.
Procedure
We performed a cross-sectional study with comprehensive echocardiography in 138 adult survivors of childhood ALL, median 23.4 years after diagnosis. Pulsed tissue Doppler measurements of early diastolic mitral annular velocities (e’) were used for the assessment of diastolic function, and compared to 138 matched controls. Of the survivors, 133 also performed ergospirometry measuring peak oxygen uptake (VO2max). Associations between cancer treatment, LV function, and VO2max were analyzed.
Results
The survivor group had lower e’ values than controls (e’ septal 11.0 vs. 12.6 cm/s, P < 0.001), but the difference was confined to the subgroup of anthracycline treated survivors (median cumulative dose 120 mg/m2). Anthracycline exposure was inversely correlated with e’ (regression coefficient −1.581, P = 0.009). Reduced VO2max/kg occurred in 47% of the survivors, but more often in anthracycline treated survivors (56%) than anthracycline naive survivors (17%, P < 0.001). Anthracycline exposure was inversely correlated with VO2max/kg (regression coefficient −3.084, P = 0.05 in multivariate analysis). Furthermore, associations were observed between measures of LV function and VO2max/kg, and e’ was the best predictor of VO2max/kg (standardized coefficient 0.355, P < 0.001 in multivariate analysis).
Conclusions
Adult survivors of childhood ALL have increased risk for impaired LV diastolic function and impaired exercise capacity, both associated with previous anthracycline exposure. Furthermore, there is an association between LV diastolic function and exercise capacity. Pediatr Blood Cancer 2015;62:1437–1443. © 2015 Wiley Periodicals, Inc.
44 citations
••
TL;DR: This study found no significant effect of OXC in treatment of agitation and aggression in patients with dementia.
Abstract: Background/Aims: To evaluate the efficacy of oxcarbazepine (OXC) in the treatment of agitation and aggression in patients with Alzheimer’s disease, vascular dementia or both.
44 citations
••
TL;DR: The findings suggest that iron supplementation in pregnancy is likely to have resulted in a low prevalence of postpartum anemia, and calls for intervention targeting newborns and infants are suggested.
Abstract: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
44 citations
Authors
Showing all 390 results
Name | H-index | Papers | Citations |
---|---|---|---|
Bjørn Moum | 60 | 220 | 12824 |
Knut Engedal | 59 | 398 | 14223 |
Per Olav Vandvik | 54 | 221 | 12488 |
Trond Markestad | 54 | 216 | 9846 |
Per Andersen | 52 | 142 | 13964 |
Jan Aaseth | 45 | 230 | 6286 |
Geir Selbæk | 42 | 249 | 10334 |
Ola E. Dahl | 41 | 105 | 13117 |
Martin A. Walter | 38 | 111 | 5835 |
Tor A. Strand | 37 | 203 | 5598 |
Marit S. Jordhøy | 35 | 64 | 3712 |
Lars Lien | 35 | 168 | 4103 |
Jørgen G. Bramness | 32 | 215 | 3965 |
Bettina S. Husebo | 32 | 120 | 3563 |
Jūratė Šaltytė Benth | 32 | 149 | 3667 |